Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2015
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies
S Postel-Vinay, S Aspeslagh, E Lanoy, et al.
Bone Marrow Transplantation
|
April 24, 2007
Graft-versus-tumour effect in refractory metastatic neuroblastoma
A Marabelle, C Paillard, A Tchirkov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 13, 2021
High levels of TNFα in patients with COVID-19 refractory to tocilizumab
F X Danlos, F Ackermann, J Rohmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2016
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
J M Pitt, A Marabelle, A Eggermont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
T Shekarian, S Valsesia-Wittmann, J Brody, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2017
Fever reaction and haemophagocytic syndrome induced by immune checkpoint inhibitors
J-M Michot, R Pruvost, C Mateus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2017
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
T Shekarian, S Valsesia-Wittmann, J Brody, et al.
Cell Death and Differentiation
|
April 16, 2016
The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
T Yamazaki, J M Pitt, M Vétizou, et al.
Bone Marrow Transplantation
|
November 26, 2008
Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model
J Kanold, C Paillard, A Tchirkov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 16, 2017
Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy
W Boisseau, M Touat, G Berzero, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2015
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies
S Postel-Vinay, S Aspeslagh, E Lanoy, et al.
Bone Marrow Transplantation
|
April 24, 2007
Graft-versus-tumour effect in refractory metastatic neuroblastoma
A Marabelle, C Paillard, A Tchirkov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 13, 2021
High levels of TNFα in patients with COVID-19 refractory to tocilizumab
F X Danlos, F Ackermann, J Rohmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2016
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
J M Pitt, A Marabelle, A Eggermont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2019
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
T Shekarian, S Valsesia-Wittmann, J Brody, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2017
Fever reaction and haemophagocytic syndrome induced by immune checkpoint inhibitors
J-M Michot, R Pruvost, C Mateus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2017
Pattern recognition receptors: immune targets to enhance cancer immunotherapy
T Shekarian, S Valsesia-Wittmann, J Brody, et al.
Cell Death and Differentiation
|
April 16, 2016
The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
T Yamazaki, J M Pitt, M Vétizou, et al.
Bone Marrow Transplantation
|
November 26, 2008
Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model
J Kanold, C Paillard, A Tchirkov, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 16, 2017
Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy
W Boisseau, M Touat, G Berzero, et al.
Page
of 5